Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Observational, Non-randomized, Double Blind, Global, Multi-center Registry With an Adaptive Design, Investigating the Diagnostic Utility of Instantaneous Wave-free Ratio™ (iFR®) in Assessing Coronary Stenosis Relevance.

NCT01740895 is registered in ClinicalTrials.gov with Volcano Corporation as lead sponsor.

NCT NCT01740895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01740895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Observational, Non-randomized, Double Blind, Global, Multi-center Registry With an Adaptive Design, Investigating the Diagnostic Utility of Instantaneous Wave-free Ratio™ (iFR®) in Assessing Coronary Stenosis Relevance.
Lead sponsor
Volcano Corporation
Phase
Observational
Overall status
Completed
Start date
December 31, 2012
Completion date
June 30, 2013
Enrollment
818 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease